E D Zanjani
Overview
Explore the profile of E D Zanjani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
187
Citations
2025
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Porada C, Sanada C, Long C, Wood J, Desai J, Frederick N, et al.
J Thromb Haemost
. 2009 Dec;
8(2):276-85.
PMID: 19943872
Background: Large animal models that accurately mimic human hemophilia A (HA) are in great demand for developing and testing novel therapies to treat HA. Objectives: To re-establish a line of...
2.
Almeida-Porada G, Crapnell K, Porada C, Benoit B, Nakauchi H, Quesenberry P, et al.
Br J Haematol
. 2005 Jul;
130(2):276-83.
PMID: 16029457
The fetal sheep model was used to compare the in vivo haematopoietic potential of human neural stem cells (NSC) versus bone marrow (BM)-derived haematopoietic stem cells (HSC). To this end,...
3.
da Silva C, Goncalves R, Lemos F, Lemos M, Zanjani E, Almeida-Porada G, et al.
Bioprocess Biosyst Eng
. 2003 Sep;
25(6):365-9.
PMID: 13680337
In this study, we described the modelling of the expansion/maintenance of human hematopoietic stem/progenitor cells from adult human bone marrow. CD 34(+)-enriched cell populations from bone marrow were cultured in...
4.
Almeida-Porada G, Porada C, Zanjani E
Rev Clin Exp Hematol
. 2001 Aug;
5(1):26-41.
PMID: 11486730
The ability to selectively produce one or more differentiated cell types at will from totipotent stem cells would be of profound clinical importance, as it would enable the specific replacement...
5.
Giesert C, Almeida-Porada G, Scheffold A, Kanz L, Zanjani E, Buhring H
Ann N Y Acad Sci
. 2001 Jul;
938:175-83.
PMID: 11458505
We recently raised a monoclonal antibody, termed W7C5, against a surface antigen that is expressed at low levels on bone marrow and peripheral blood CD34+ stem/progenitor cells but at high...
6.
Lewis I, Almeida-Porada G, Du J, Lemischka I, Moore K, Zanjani E, et al.
Blood
. 2001 May;
97(11):3441-9.
PMID: 11369635
This report describes stroma-based and stroma-free cultures that maintain long-term engrafting hematopoietic cells for at least 14 days ex vivo. Umbilical cord blood (UCB) CD34(+) cells were cultured in transwells...
7.
Tran N, Porada C, Almeida-Porada G, GLIMP H, Anderson W, Zanjani E
Blood
. 2001 May;
97(11):3417-23.
PMID: 11369632
The successful transduction of hematopoietic stem cells and long-term (28 months) transgene expression within the hematopoietic system following the direct injection of high-titer retroviral vectors into preimmune fetal sheep was...
8.
Almeida-Porada G, Brown R, MacKintosh F, Zanjani E
J Hematother Stem Cell Res
. 2000 Nov;
9(5):683-93.
PMID: 11091492
To develop culture conditions devoid of serum that would support the ex vivo expansion and maintenance of hematopoietic stem cells (HSC) with engraftment capability, we performed in vitro studies in...
9.
Verfaillie C, Almeida-Porada G, Wissink S, Zanjani E
Exp Hematol
. 2000 Sep;
28(9):1071-9.
PMID: 11008020
Objective: Mobilized peripheral blood (PB) progenitors are increasingly used in autologous and allogeneic transplantation. However, the short- and long-term engraftment potential of mobilized PB or bone marrow (BM) has not...
10.
Porada C, Tran N, Zhao Y, Anderson W, Zanjani E
Exp Hematol
. 2000 Jul;
28(6):642-50.
PMID: 10880750
We investigated whether gene transfer into hematopoietic cells could be achieved by direct injection of retroviral vector supernatant into the bone marrow space of newborn sheep. Six sheep (5 weeks...